Spatial coupling of endogenous Tau translation and degradation by neuroproteasomes in dendrites revealed by STARFISH

Kd Konrad-Vicario, V Paradise, L. Demir, Cd Makinson, Ming Zhou, K L RamachandranbioRxiv 2025 · DOI

TL;DR

This paper introduces STARFISH, a novel method to pinpoint where proteins are synthesized within cells with unprecedented spatial resolution. Using STARFISH, the researchers discovered that Tau protein, implicated in Alzheimer's disease, is exclusively translated in neuronal dendrites and is rapidly degraded by a specialized proteasome in the same location. This suggests a new mechanism for Alzheimer's pathology where a failure in this dendritic Tau degradation system leads to Tau aggregation.

What Problem Does This Paper Address?

Understanding how cells maintain protein homeostasis (proteostasis) is crucial, especially in neurons where protein synthesis and degradation must be tightly controlled in distinct cellular compartments. Alzheimer's disease (AD) is characterized by the aggregation of Tau protein, which mislocalizes from its normal axonal location to the somatodendritic compartment. While the mislocalization of Tau is known, the precise subcellular dynamics of its synthesis and degradation have remained poorly understood. Existing methods for tracking protein synthesis often require modifying the proteins or mRNAs, which can alter their behavior, or lack the spatial resolution to pinpoint synthesis to specific subcellular locations like dendrites. This lack of understanding hinders our ability to grasp how Tau aggregation occurs and how to potentially intervene.

Methods

The core innovation presented is STARFISH (subcellular translation of endogenous RNA-FISH). This technique combines single-molecule Fluorescence In Situ Hybridization (smFISH) with ultra-efficient proximity ligation assays (PLA). Here's how it works:

  • Targeting mRNA and Ribosomes: Probes are designed to bind to both a specific mRNA (in this case, Mapt for Tau) and the 18S ribosomal RNA (rRNA) of translating ribosomes. These probes are "clickable," meaning they have chemical handles that can be linked together.
  • Proximity Ligation: When an mRNA is actively being translated, the ribosome is in close proximity to the mRNA. The clickable probes on both the mRNA and the ribosome can then be ligated together.
  • Signal Amplification: A subsequent step amplifies this ligated signal, making it detectable with high sensitivity.
  • Near-Codon Resolution: The probes are designed to be very close to each other, allowing for visualization of translation events with near-codon resolution, meaning they can pinpoint the exact location of translation with remarkable precision.
  • No Modification Required: Crucially, STARFISH visualizes the endogenous mRNA and ribosomes without modifying the nascent polypeptide or the mRNA sequence, thus avoiding artifacts seen with other methods.

The researchers also employed standard techniques like:

  • Puromycin pulse: Puromycin is incorporated into nascent polypeptides, causing ribosomes to detach from mRNA. A loss of STARFISH signal after puromycin treatment confirms that the signal originates from actively translating ribosomes.
  • Homoharringtonine (HHT) runoff assays: HHT stalls ribosomes at the initiating AUG codon, allowing researchers to determine the minimum distance between probes required for a positive STARFISH signal, thus assessing spatial resolution.
  • Immunoprecipitation (IP) and radiolabeling: Used to track the synthesis and degradation kinetics of newly synthesized Tau.
  • Sarkosyl fractionation: A standard method to separate soluble and insoluble protein fractions, used to assess protein aggregation.
  • Immunohistochemistry: Used to visualize protein localization and phosphorylation in brain tissue.

Datasets

The study primarily uses primary mouse hippocampal neurons and brain tissue from hTau-knock-in mice. No specific public datasets were used for training or evaluation; rather, the experiments generated novel data using the developed STARFISH technique and established biological models.

Key Insights and Ideas

  • Dendrites are Tau Translation Hubs: Despite Mapt mRNA being found throughout neurons, Tau protein synthesis is almost exclusively localized to neuronal dendrites. This is a significant spatial regulation that was previously unappreciated.
  • Rapid Dendritic Degradation of New Tau: Approximately 30% of newly synthesized Tau is rapidly degraded (within 30-60 seconds) in dendrites by a specialized, neuronal-specific proteasome called the "neuroproteasome."
  • Neuroproteasome as a Quality Control Mechanism: This rapid degradation suggests the neuroproteasome acts as a crucial quality control mechanism, preventing the accumulation of potentially misfolded or aggregated Tau.
  • Failure of Neuroproteasome = Tau Aggregation: Inhibiting the neuroproteasome leads to the accumulation of somatodendritically mislocalized Tau, which can then aggregate into pathological filaments. This directly links neuroproteasome dysfunction to Tau pathology in AD.
  • STARFISH's Superiority: STARFISH offers significantly higher signal-to-noise and spatial resolution compared to existing methods like puromycin-based assays, which can be confounded by diffusion of labeled peptides.

Key Results

  • STARFISH successfully visualized the subcellular localization of translation for several mRNAs (Arc, Camk2a, Actb) in primary neurons and in vivo, demonstrating its broad applicability.
  • STARFISH-Mapt showed that Tau translation occurs exclusively in dendrites, with no detectable signal in the soma or axons, despite the presence of Mapt mRNA and ribosomes in these compartments.
  • Pulse-chase experiments revealed that nearly 50% of newly synthesized Tau is degraded within 30-60 seconds, and this degradation is significantly reduced by inhibiting the neuroproteasome.
  • Inhibition of neuroproteasomes led to a ~3.5-fold increase in Puro-PLA-Tau signal, indicating impaired degradation of newly synthesized Tau.
  • STARFISH-Mapt signal showed significant co-localization with neuroproteasomes in dendrites, supporting the idea that neuroproteasomes are positioned to degrade newly synthesized Tau.
  • Inhibition of translation (using cycloheximide) blocked neuroproteasome-dependent Tau aggregation in both cell cultures and in vivo, confirming that de novo protein synthesis is required for this aggregation.

Limitations and Future Work

  • Mechanism of Dendritic Tau Synthesis Restriction: While the study shows Tau is synthesized in dendrites, the precise mechanisms that restrict Mapt mRNA translation to this compartment, despite its presence elsewhere, remain to be elucidated. The authors suggest this spatial segregation might be a protective mechanism.
  • Function of Rapid Degradation: The exact biological function of the rapid degradation of newly synthesized Tau by neuroproteasomes is still under investigation. Two hypotheses are proposed: either the degradation releases functional fragments into the extracellular space, or it serves as a quality control mechanism for potentially defective Tau. Future work will explore if this proteolytic processing is neuroproteasome-dependent and has biological function.
  • Tau Phosphorylation Model: The precise role of Tau phosphorylation in the context of neuroproteasome-dependent Tau aggregation needs further clarification. While phosphorylation is linked to aggregation, it's not always a direct determinant.
  • Neuroproteasome-Specific Inhibitors: The development of neuroproteasome-specific inhibitors is highlighted as a crucial tool for future studies, particularly for investigating the biological function of this proteolytic processing.
  • Broader Applications of STARFISH: The authors envision STARFISH and its derivatives being valuable for studying RNA binding protein interactions, the impact of RNA structure on translation, and any scenario requiring high-resolution visualization of RNA-protein interactions.

Summary updated

Abstract

Cells regulate protein synthesis, folding, and degradation to maintain proteostasis, and disruptions in these processes have been linked to neurodegenerative diseases. In Alzheimer’s disease (AD), the protein Tau mislocalizes from axons to the somatodendritic compartment and aggregates into pathological filaments. Although Tau aggregation is a hallmark of AD, the subcellular dynamics of its synthesis and degradation are not well characterized. Because nascent polypeptides are particularly susceptible to misfolding, local control of Tau synthesis and degradation may be essential to prevent aggregation. Here, we develop STARFISH, a method for visualizing the subcellular site of endogenous mRNA translation in primary neurons and in vivo with single-molecule sensitivity and near-codon resolution, without modifying the nascent polypeptide. Using STARFISH, we show that despite the broad distribution of Mapt mRNA, Tau is translated almost exclusively in neuronal dendrites, revealing an unexpected level of spatial regulation. We further identify that one-third of newly synthesized Tau is co- or peri-translationally degraded in dendrites by a neuronal-specific plasma membrane-associated proteasome, the neuroproteasome. Failure of neuroproteasome-mediated degradation leads to the protein synthesis-dependent accumulation of somatodendritically mislocalized Tau aggregates. These findings define a previously unrecognized proteostasis mechanism that counterbalances the constitutive physiological overproduction of Tau. We speculate that failure of this proteostasis system contributes directly to Tau aggregation in dendrites, defining a new pathomechanism in Alzheimer’s disease.
BibTeX
@misc{konradvicario2025spatial,
  author = {KD Konrad-Vicario and V Paradise and L. Demir and CD Makinson and Ming Zhou and K L Ramachandran},
  title = {{Spatial coupling of endogenous Tau translation and degradation by neuroproteasomes in dendrites revealed by STARFISH}},
  year = {2025},
  doi = {10.1101/2025.06.04.657939},
  howpublished = {bioRxiv},
}
Figure